KRASG12C IN-14
Ref. TM-T200204
10mg | To inquire | ||
50mg | To inquire |
Product Information
KRASG12C IN-14 (compound 15), a potent inhibitor specifically designed for the KRAS G12C mutation, exhibits impressive efficacy in impeding CYPA-dependent KRAS-BRAF interaction and ERK phosphorylation in NCI-H358 cells, both with an IC 50 of 0.002 μM.
Chemical properties
Technical inquiry about: TM-T200204 KRASG12C IN-14
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.